MARKET

IDXX

IDXX

Idexx Labs Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

372.23
+7.40
+2.03%
After Hours: 372.23 0 0.00% 16:10 05/20 EDT
OPEN
370.61
PREV CLOSE
364.83
HIGH
375.13
LOW
362.74
VOLUME
768.22K
TURNOVER
0
52 WEEK HIGH
706.95
52 WEEK LOW
330.66
MARKET CAP
31.27B
P/E (TTM)
43.69
1D
5D
1M
3M
1Y
5Y
Calculating The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
How far off is IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) from its intrinsic value? Using the most recent financial data...
Simply Wall St. · 3d ago
Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $530 From $615, Maintains Neutral Rating
MT Newswires · 4d ago
IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Jaws & Paws Conference on Wednesday, June 1, 2022. Jay Mazelsky, President and C...
PR Newswire · 4d ago
Baron Funds: “We Expect IDEXX’s Margins to Continue to Improve”
Baron Funds, an asset management firm, published its “Baron Asset Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. Baron Asset Fund (the “Fund”) fell 14.52% (Institutional Shares), while the Russell Midcap Growth Index (th...
Insider Monkey · 4d ago
IDEXX Laboratories Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q1, IDEXX Laboratories (NASDAQ:IDXX) earned $193.97 million, a 19.16% increase from the preceding quarter. IDEXX Laboratories also posted a total of $836.55 million in sales, a 4.43% increase since Q4.
Benzinga · 5d ago
11 Companies in Focus After Releasing Their Earnings Reports
In this article, we will take a look at the 11 companies in focus after releasing their earnings reports. You can skip our detailed analysis of these companies and go directly to the 5 Companies in Focus After Releasing Their Earnings Reports. Notable cons...
Insider Monkey · 05/05 19:04
IDEXX Laboratories stock slips on mixed Q1 earnings, cut in FY revenue and EPS guidance
IDEXX Laboratories (NASDAQ:IDXX) stock has lost 6.5% to $384.78 in Thursday afternoon trade, after the veterinary services company reported a mixed set of Q1 2022 earnings and cut its FY
Seekingalpha · 05/05 17:38
IDEXX downgraded at BofA citing “soft 2022 start”
IDEXX Laboratories (NASDAQ:IDXX) has extended the post-earnings losses to the second straight session on Thursday after Bank of America lowered its rating on the animal health company to Neutral from
Seekingalpha · 05/05 17:06
More
No Data
Learn about the latest financial forecast of IDXX. Analyze the recent business situations of Idexx Labs Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

18.18%Strong Buy
36.36%Buy
45.45%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average IDXX stock price target is 563.00 with a high estimate of 700.00 and a low estimate of 470.00.
High700.00
Average563.00
Low470.00
Current 372.23
EPS
Actual
Estimate
0.581.171.752.34
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 1.30K
Institutional Holdings: 86.38M
% Owned: 102.83%
Shares Outstanding: 84.01M
TypeInstitutionsShares
Increased
343
3.47M
New
73
1.80M
Decreased
393
3.58M
Sold Out
134
618.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.35%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Non-Executive Chairman/Independent Director
Lawrence Kingsley
President/Chief Executive Officer/Director
Jonathan Mazelsky
Chief Financial Officer/Executive Vice President/Treasurer
Brian Mckeon
Chief Human Resource Officer/Senior Vice President
Michael Johnson
Executive Vice President/Chief Technology Officer
Martin Smith
Executive Vice President/General Counsel/Secretary
Sharon Underberg
Executive Vice President/General Manager
Tina Hunt
Executive Vice President/General Manager
Michael Lane
Executive Vice President
James Polewaczyk
Senior Vice President/Chief Marketing Officer
Kathy Turner
Director
Jonathan Ayers
Independent Director
Bruce Claflin
Independent Director
Asha Collins
Independent Director
Stuart Essig
Independent Director
Daniel Junius
Independent Director
Sam Samad
Independent Director
M. Anne Szostak
Independent Director
Sophie Vandebroek
No Data
No Data
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Webull offers kinds of IDEXX Laboratories, Inc. stock information, including NASDAQ:IDXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXX stock methods without spending real money on the virtual paper trading platform.